Centre for Drug Research and Development:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centre for Drug Research and Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9384
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides scientific infrastructure to transform discoveries into innovative therapeutic products and improved health outcomes. The center’s drug development platform includes target validation, screening, drug delivery, medicinal chemistry, pharmacology and toxicology, biologics and external platforms. It spans its expertise in the therapeutic areas of neuroscience, oncology, inflammation, fibrosis and other indications. CDRD’s target validation programs comprise vivo efficacy model development, assay development and transfer, and others. The center has also established national, provincial, and international partnerships, and developed specially-trained highly-qualified personnel. CDRD is headquartered in Vancouver, British Columbia, Canada.

Centre for Drug Research and Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Drug Research and Development, Medical Devices Deals, 2012 to YTD 2018 9
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 11
Partnerships 13
Schrodinger Enters into Partnership with Centre for Drug Research and Development 13
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 14
Novelogics Biotech Enters into Research Agreement with Centre for Drug Research and Development 15
Centre for Drug Research and Development Partners with AstraZeneca 16
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 17
Centre for Drug Research and Development and Centre Hospitalier Universitaire de Sherbrooke Enter into Development Partnership 18
Licensing Agreements 19
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 19
Centre for Drug Research and Development – Key Employees 20
Centre for Drug Research and Development – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Oct 15, 2018: CDRD appoints Didier Leconte to Its Board of Directors 22
Oct 11, 2017: CDRD Announces Appointments to its Board of Directors 23
May 01, 2017: CDRD appoints CFO 24
May 01, 2017: CDRD Appoints Matthew J. Carlyle Chief Financial Officer 25
Feb 01, 2017: CDRD Appoints Gordon McCauley as President and CEO 26
Government and Public Interest 27
Mar 09, 2017: Stem Cell & Regenerative Medicine Leaders Join Forces to Advance Canada’s Position in the Field 27
Product News 28
Jun 27, 2017: LifeArc, Dstl and CDRD Collaborate to Identify Antibacterial Drug Targets 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Key Facts 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Drug Research and Development, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Drug Research and Development, Medical Devices Deals, 2012 to YTD 2018 9
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 11
Schrodinger Enters into Partnership with Centre for Drug Research and Development 13
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 14
Novelogics Biotech Enters into Research Agreement with Centre for Drug Research and Development 15
Centre for Drug Research and Development Partners with AstraZeneca 16
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 17
Centre for Drug Research and Development and Centre Hospitalier Universitaire de Sherbrooke Enter into Development Partnership 18
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 19
Centre for Drug Research and Development, Key Employees 20

List of Figures
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Drug Research and Development, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Centre for Drug Research and Development:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • George Weston Ltd (WN):企業の財務・戦略的SWOT分析
    George Weston Ltd (WN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • GAIL (India) Ltd (GAIL)-エネルギー分野:企業M&A・提携分析
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company that carries out exploration and production, transmission of natural gas. It also has presence in petrochemical, liquid hydrocarbons and power and renewable sectors. GAIL is also a major LPG transmission company, besides managing …
  • Cepheid:医療機器:M&Aディール及び事業提携情報
    Summary Cepheid, a subsidiary of Danaher Corporation, is a molecular diagnostic company that develops, manufactures and markets molecular systems and tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious d …
  • DiaMedica Therapeutics Inc (DMA):医療機器:M&Aディール及び事業提携情報
    Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 a …
  • Arcbest Corp.:企業の戦略・SWOT・財務分析
    Arcbest Corp. - Strategy, SWOT and Corporate Finance Report Summary Arcbest Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ReproCELL Inc (4978):製薬・医療:M&Aディール及び事業提携情報
    Summary ReproCELL Inc (ReproCELL) is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation materials, and cell and biorepository. Its research reagent products include hES iPSC culture reagents …
  • E.ON UK Plc:企業の戦略的SWOT分析
    E.ON UK Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Nucor Corporation:企業のM&A・事業提携・投資動向
    Nucor Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nucor Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Baoviet Holdings:企業の戦略・SWOT・財務分析
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NOV Inc (NOV):企業の財務・戦略的SWOT分析
    NOV Inc (NOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Sumitomo Electric Industries Ltd (5802):企業の財務・戦略的SWOT分析
    Sumitomo Electric Industries Ltd (5802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • CeoTronics AG (CEK):企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Calix Ltd (CXL):企業の財務・戦略的SWOT分析
    Calix Ltd (CXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • NextEra Energy Inc (NEE)-エネルギー分野:企業M&A・提携分析
    Summary NextEra Energy, Inc. (NEE), formerly FPL Group, Inc., is an energy company that generates, transmits and distributes electricity together with its subsidiaries. The company generates power through various sources such as nuclear, coal, oil and natural gas-fired facilities, and hydro power pl …
  • STP&I Public Company Limited:企業の戦略・SWOT・財務情報
    STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Endurance International Group Holdings, Inc.:企業のM&A・事業提携・投資動向
    Endurance International Group Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Endurance International Group Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Altern Energy Ltd (ALTN):企業の財務・戦略的SWOT分析
    Altern Energy Ltd (ALTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • EMCOR Group, Inc.:企業の戦略・SWOT・財務情報
    EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆